Neurology

Levetiracetam Is No More Effective Than Phenytoin in Children with Convulsive Status Epilepticus No abstract available

Antiplatelet Therapy Is Safe for Secondary Prevention of Stroke—Even with Cerebral Microbleeds No abstract available

"Chemical Plasmapheresis" Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 Trial No abstract available

New Study Links Chronic Renal Dysfunction and Proteinuria with a Risk of Parkinson's Disease in the Elderly No abstract available

Gliomas Hijack Normal Myelination. Why That May Hold the Key to New Treatments No abstract available

Lesion Network Mapping: Discovering the Common Circuits Underlying Neurologic Mysteries No abstract available

Why Newer Migraine Blockers Fail Some Patients No abstract available

A Pipeline Program Inspires Future Neurologists No abstract available

Pain Society's Expected Bankruptcy: What Does It Mean for Other Medical Associations? No abstract available

She Sees Epilepsy Patients and Heads Up Major Research Grants. Off Hours, She's Designing Fine Chocolate No abstract available

This issue is packed with expert commentary on the neurology stories that matter.  For more on what not to miss in this issue, listen to the Neurology Today Editor's Pickspodcast about these noteworthy stories: How do levetiracetam and phenytoin compare for convulsive status epilepticus? This drug for myasthenia gravis is safe and effective Meet these future neurologists: An AAN pipeline program for medical students For Your Patients       Levetiracetam Is No More Effective Than Phenytoin in Children with Convulsive Status Epilepticus Christine Lehmann Antiplatelet Therapy Is Safe for Secondary Prevention of Stroke—Even with Cerebral Microbleeds Mark Moran

In the Pipeline       "Chemical Plasmapheresis" Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 Trial Richard Robinson New Study Links Chronic Renal Dysfunction and Proteinuria with a Risk of Parkinson's Disease in the Elderly Susan Kreimer

Disease Mechanisms       Gliomas Hijack Normal Myelination. Why That May Hold the Key to New Treatments Richard Robinson Lesion Network Mapping: Discovering the Common Circuits Underlying Neurologic Mysteries Richard Robinson   At the Bench       Why Newer Migraine Blockers Fail Some Patients Kurt Samson   Professionalism       A Pipeline Program Inspires Future Neurologists Orly Avitzur   Policy and Practice       Pain Society's Expected Bankruptcy: What Does It Mean for Other Medical Associations? Gina Shaw   Off the Clock       She Sees Epilepsy Patients and Heads Up Major Research Grants. Off Hours, She's Designing Fine Chocolate Gina Shaw

Alexandros Sfakianakis
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182

6948891480

alsfakia@gmail.com